Product Program year 2025 Source: CMS Open Payments

TruFreeze

Device Gastroenterology

PDI 00724995199234

Open in the dashboard

General payments

$773,629

1,809 payments

Research payments

$26,974

22 payments

Through program year 2025, $773,629 in general payments and $26,974 in research payments were reported against TruFreeze (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $189,159 565
2024 General $195,461 545
2023 General $142,197 312
2022 General $141,895 262
2022 Research $9,650 3
2021 General $104,917 125
2021 Research $17,324 19

Breakdown

Who paid General payments · program years 2021–2025
  1. US Endoscopy $511,908 252 payments
  2. Steris Corporation $261,721 1,557 payments
Top recipients General payments · program year 2025
  1. Sonali Sethi Pulmonary Disease · New York, NY $24,504 13% · 26 payments
  2. John Erikson Yap Gastroenterology · St George, UT $15,287 8% · 22 payments
  3. Ken Yoneda Critical Care Medicine · Sacramento, CA $14,592 8% · 12 payments
  4. Laura Frye Critical Care Medicine · Salt Lake City, UT $13,794 7% · 21 payments
  5. Toufic Kachaamy Gastroenterology · Scottsdale, AZ $11,309 6% · 13 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $89,447 47% · 139 practitioners
  2. Pulmonary Disease Internal Medicine $54,133 29% · 64 practitioners
  3. Critical Care Medicine Internal Medicine $29,220 15% · 9 practitioners
  4. Otolaryngology $8,307 4% · 43 practitioners
  5. Internal Medicine $2,670 1% · 21 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $37,979 20% · 46 recipients
  2. California $27,469 15% · 54 recipients
  3. Georgia $26,761 14% · 13 recipients
  4. Virginia $20,497 11% · 5 recipients
  5. Utah $15,702 8% · 4 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,809 general · 22 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record